Politics · Philippines Bureau
Tulfo questions FDA chief's appointment, cites alleged Teston ties
A Philippine senator raised concerns about potential nepotism in the Food and Drug Administration's leadership during a budget hearing, questioning whether the newly appointed officer-in-charge secured the position through questionable connections.
LSN Philippines ·
Senator Raffy Tulfo challenged the credentials of newly appointed Food and Drug Administration Officer-in-Charge Franklin Anthony Tabaquin IV during a Senate Committee on Finance hearing on Friday, alleging the appointment may have been influenced by ties to former FDA chief Paolo Teston.
The interrogation occurred during the committee's review of the Department of Health's budget allocation, where Tulfo pressed Tabaquin IV on the circumstances surrounding his elevation to the leadership position. The senator's questions centered on whether the appointment process followed proper procedures or whether personal connections played a determining role.
The exchange highlighted ongoing concerns within the Senate regarding leadership appointments at key health agencies and the potential for conflicts of interest. The FDA, which oversees the regulation of pharmaceuticals, medical devices, and food products, is a critical institution in the Philippine health system.
Tabaquin IV's appointment as OIC represents a temporary leadership arrangement pending a permanent replacement for the FDA chief position. The senator's intervention suggests continued legislative scrutiny of personnel decisions at major government health bodies.